- Pediatric Specialty Center at Long Wharf1 Long Wharf DriveNew Haven, CT 06511
Laura Marie Nally, MD
Biography
Long before she knew she would become a pediatric endocrinologist, Laura Nally, MD, was familiar with type 1, or juvenile, diabetes. Her father and two of her aunts had the chronic condition, in which the pancreas creates too little or no insulin, a hormone needed to move blood sugar (glucose) to the body’s cells to be used for energy.
When she was 6, Dr. Nally was diagnosed with type 1 diabetes herself. “I’ve lived with it ever since. As I grew older, I knew I wanted to contribute to helping others with their management of type 1 diabetes,” says Dr. Nally, who specializes in treating children with diabetes and other hormonal problems. “When I was 12, I started to better understand how to manage the disease, and it became more interesting to me. Each day was like a science experiment. I’d take a certain amount of insulin, eat something, and then see what happened throughout the day.”
That fascination prompted her career in medicine. Pediatrics, she says, was a natural fit. “Kids are fantastic. I love working with them. I can be goofy and silly, which suits me naturally. It’s so nice to bond with them about diabetes,” she adds. “When I say, ‘Oh look, I have an insulin pump, too,’ the younger ones especially love that.”
Dr. Nally says she especially likes working with teenagers who have diabetes. “Life is difficult enough when you’re a teen, and to manage diabetes when you have 30 other things going on that are much more important to you is challenging,” she says. “I want to inspire them to take their insulin, to do their blood-sugar checks, but to not feel like their whole world revolves around diabetes. I think it helps for them to see me, a healthy, happy adult with diabetes who hasn’t let it stop her from achieving her dreams.”
Titles
- Assistant Professor of Pediatrics
- Assistant Professor, Pediatric Endocrinology & Diabetes
Education & Training
- FellowshipStanford University (2018)
- Pediatrics ResidentUC Irvine/CHOC Children's Hospital (2015)
- Pediatrics InternUC Irvine/CHOC Children's Hospital (2013)
- General Surgery InternUniversity of Rochester (2011)
- MDUC Davis School of Medicine (2010)
- BSRice University
Additional Information
- Letter of Distinction in Clinical Teaching: Stanford University School of Medicine (2018)
- Pediatric Outpatient Teaching Award: Stanford University School of Medicine (2017)
- Alpha Omega Alpha Honor Medical Society: Stanford University School of Medicine (2017)
- AAP Young Physician Community Engagement Award: American Academy of Pediatrics (2013)
- Gabriel Smilkstein Humanitarian Award: UC Davis School of Medicine (2010)
- Gold Foundation Scholarship: Gold Foundation (2010)
- Doctors For America (2021 - Present): Member
- American Academy of Pediatrics (2019 - Present): Member
- Borden C, Bakkila B, Nally L, Lipska K. The Association Between Cost-Related Insulin Rationing and Health Care Utilization in U.S. Adults With Diabetes. Diabetes Care 2025, 48: 400-404. PMID: 39746142, PMCID: PMC11870294, DOI: 10.2337/dc24-2117.
- Nally L, Sherr J. Making diabetes technology accessible to all. Nature Medicine 2024, 30: 1832-1833. PMID: 38918631, DOI: 10.1038/s41591-024-03082-8.
- Nally L, Sherr J, Tichy E, Weyman K, Urban A, Shabanova V, McCollum S, Steffen A, Tamborlane W, Van Name M. Impact of school‐supervised ultra‐long‐acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study. Diabetic Medicine 2023, 40: e15123. PMID: 37078999, PMCID: PMC10524154, DOI: 10.1111/dme.15123.
- Sherr J, Nally L. Continuous ketone monitoring for diabetes: a new era for diabetes. The Lancet Diabetes & Endocrinology 2025, 13: 736-738. PMID: 40812954, DOI: 10.1016/s2213-8587(25)00220-7.
- Nally L, Sherr J, Garg S, Marks B, Laffel L, Pihoker C, Accacha S, Thrasher J, Abuzzahab M, Reed J, Ekhlaspour L, Belapurkar S, Shulman D, Sunil B, MacLeish S, Latif K, Forlenza G, Castorino K, Lal R, Bode B, Broyles F, Carlson A, Nwosu B, Shin J, Ma H, Salbato A, Cordero T, Treminio Y, McVean J, Rhinehart A, Vigersky R, Group F. Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor. Diabetes Technology & Therapeutics 2025 PMID: 40824839, DOI: 10.1177/15209156251368928.
- Igudesman D, Nally L, Grimshaw A, Gunderson C, Considine E, Jacobsen L, Tosur M, Gottlieb P, Hirsch I, Laffel L, Sherr J, Mathieu C, Pratley R. Dietary Patterns for Weight and Glycemic Management in Persons With Type 1 Diabetes: A Meta-analysis of Clinical Trials. The Journal Of Clinical Endocrinology & Metabolism 2025, dgaf448. PMID: 40795275, DOI: 10.1210/clinem/dgaf448.
- FITCH R, MOULD D, SHERR J, LAFFEL L, NALLY L, FERGUSON N. 2070-LB: Modeling to Assess the Impact of Liquid, Stable Glucagon for Mini-dosing in Pediatrics—A Simulated Pharmacokinetic and Pharmacodynamic Study. Diabetes 2025, 74 DOI: 10.2337/db25-2070-lb.
- ASH G, NALLY L, LUKASIK J, MAK S, GRIGGS S, (ELIAS) SPANAKIS I, FUCITO L, WEINZIMER S. 1904-LB: Usability and Acceptability of a Biometric Dashboard with Tailored Coaching Tips for Exercise by Adults with Type 1 Diabetes. Diabetes 2025, 74 DOI: 10.2337/db25-1904-lb.
- ASH G, MAK S, (ELIAS) SPANAKIS I, LUKASIK J, NALLY L, FUCITO L, WEINZIMER S. 1109-P: Physician Referral Pathway to a Commercially Marketed Digital Exercise Resource for Type 1 Diabetes—Implementation Metrics from a Clinical Trial. Diabetes 2025, 74 DOI: 10.2337/db25-1109-p.
- NALLY L, LUKASIK J, HERZOG R, MITTENDORFER B, GOSS A, SAVOYE M, ROSE P, MCCOLLUM S, SHABANOVA V, SHERR J. 1186-P: A Short-Term Low Carbohydrate Diet Improves Glycemia in Adolescents and Young Adults with Type 1 Diabetes—Results from a Randomized Crossover Study. Diabetes 2025, 74 DOI: 10.2337/db25-1186-p.
- Mak S, Nally L, Montoya J, Marrero R, DeJonckheere M, Joiner K, Nam S, Ash G. An Exergames Program for Adolescents With Type 1 Diabetes: Qualitative Study of Acceptability. JMIR Diabetes 2025, 10: e65665. PMID: 40238214, PMCID: PMC12159555, DOI: 10.2196/65665.
- Harel S, Lukasik J, Wilcox A, Lipska K, Weinzimer S, Suttiratana S, Nally L. “Can I afford to live today?” The emotional toll of navigating the healthcare system with type 1 diabetes. Frontiers In Endocrinology 2025, 16: 1555265. PMID: 40196455, PMCID: PMC11973976, DOI: 10.3389/fendo.2025.1555265.
- Blanchette J, Nally L, Wentzell K, Hughes A, Allen N, Litchman M. Insights on Improving Health Insurance Literacy in Diabetes. The Journal Of Clinical Endocrinology & Metabolism 2025, 110: s175-s186. PMID: 39998926, PMCID: PMC12054720, DOI: 10.1210/clinem/dgae706.
- O’Donovan A, Gorelik S, Nally L. Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies. Frontiers In Endocrinology 2025, 15: 1548761. PMID: 39936148, PMCID: PMC11811703, DOI: 10.3389/fendo.2024.1548761.
- O’Donovan A, Gorelik S, Nally L. Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies. Frontiers In Endocrinology 2024, 15: 1477101. PMID: 39568817, PMCID: PMC11576206, DOI: 10.3389/fendo.2024.1477101.
- Nally L, Blanchette J. Integrated Strategies to Support Diabetes Technology in Pregnancy. Obstetrics And Gynecology 2024, 144: 599-607. PMID: 39208437, PMCID: PMC11486578, DOI: 10.1097/aog.0000000000005710.
- Ash G, Nally L, Stults-Kolehmainen M, De Los Santos M, Jeon S, Brandt C, Gulanski B, Spanakis E, Baker J, Weinzimer S, Fucito L. Personalized Digital Health Information to Substantiate Human-Delivered Exercise Support for Adults With Type 1 Diabetes. Clinical Journal Of Sport Medicine 2023, 33: 512-520. PMID: 36715983, PMCID: PMC10898917, DOI: 10.1097/jsm.0000000000001078.
- Nally, LM, Sherr, JL, Tichy, E, et al. Impact of school-supervised ultra-long-acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study. Diabet Med. 2023; 00:e15123. doi:10.1111/dme.15123
- Wilcox A, Lipska K, Weinzimer S, Gujral J, Arakaki A, Kerandi L, Nally L. Navigating barriers to affording and obtaining insulin and diabetes supplies. Journal Of Diabetes 2022, 15: 71-75. PMID: 36562281, PMCID: PMC9870729, DOI: 10.1111/1753-0407.13344.
- Deshpande S, Weinzimer SA, Gibbons K, Nally LM, Weyman K, Carria L, Zgorski M, Laffel LM, Doyle FJ, Dassau E. Feasibility and Preliminary Safety of Smartphone-Based Automated Insulin Delivery in Adolescents and Children With Type 1 Diabetes. Journal Of Diabetes Science And Technology 2022, 18: 363-371. PMID: 35971681, PMCID: PMC10973844, DOI: 10.1177/19322968221116384.
- WILCOX A, MENCHER S, NALLY L, WEINZIMER S. 1025-P: Racial Disparities in Diabetes Distress and Technology Use in Adolescents with Type 1 Diabetes. Diabetes 2022, 71 DOI: 10.2337/db22-1025-p.
- Mencher SR, Weinzimer SA, Nally LM, Van Name M, Nunez-Smith M, Sadler LS. Technology Utilization in Black Adolescents with Type 1 Diabetes: Exploring the Decision-Making Process. Diabetes Technology & Therapeutics 2022, 24: 249-257. PMID: 35085444, PMCID: PMC11074720, DOI: 10.1089/dia.2021.0413.
- Nally LM. A commentary on: Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System. PracticeUpdate website. Available at: https://www.practiceupdate.com/content/qualitative-study-of-user-experiences-with-loop-an-open-source-automated-insulin-delivery-system/138310/65/8/1. Accessed July 21, 2022
- Waikar AR, Arora T, Haynes M, Tamborlane WV, Nally LM. Case Report: Managing Pregnancy With Type 1 Diabetes Using a Do-It-Yourself Artificial Pancreas System. Clinical Diabetes 2021, 39: 441-444. PMID: 34866788, PMCID: PMC8603326, DOI: 10.2337/cd20-0128.
- Ash GI, Stults-Kolehmainen M, Busa MA, Gaffey AE, Angeloudis K, Muniz-Pardos B, Gregory R, Huggins RA, Redeker NS, Weinzimer SA, Grieco LA, Lyden K, Megally E, Vogiatzis I, Scher L, Zhu X, Baker JS, Brandt C, Businelle MS, Fucito LM, Griggs S, Jarrin R, Mortazavi BJ, Prioleau T, Roberts W, Spanakis EK, Nally LM, Debruyne A, Bachl N, Pigozzi F, Halabchi F, Ramagole DA, Janse van Rensburg DC, Wolfarth B, Fossati C, Rozenstoka S, Tanisawa K, Börjesson M, Casajus JA, Gonzalez-Aguero A, Zelenkova I, Swart J, Gursoy G, Meyerson W, Liu J, Greenbaum D, Pitsiladis YP, Gerstein MB. Establishing a Global Standard for Wearable Devices in Sport and Exercise Medicine: Perspectives from Academic and Industry Stakeholders. Sports Medicine 2021, 51: 2237-2250. PMID: 34468950, PMCID: PMC8666971, DOI: 10.1007/s40279-021-01543-5.
- WILCOX A, KERANDI L, LIPSKA K, WEINZIMER S, NALLY L. 49-LB: Navigating Barriers to Affording and Obtaining Diabetes Treatment. Diabetes 2021, 70 DOI: 10.2337/db21-49-lb.
- Kravetz AM, Sanghavi P, Bhargava V, Shi RZ, Nally LM. Plasmapheresis as an Early Treatment for Severe Hypertriglyceridemia, Acute Pancreatitis, and Diabetic Ketoacidosis. AACE Clinical Case Reports 2021, 7: 315-319. PMID: 34522772, PMCID: PMC8426612, DOI: 10.1016/j.aace.2021.03.009.
- John-Henderson NA, Wright RC, Manke KJ, Fotuhi O, Zuckerman B, Nally L, Mueller CM. The Influence of Health Mindset on Perceptions of Illness and Behaviors Among Adolescents. International Journal Of Behavioral Medicine 2021, 28: 727-736. PMID: 33721232, DOI: 10.1007/s12529-021-09972-2.
- Nally L, Van Name M, Tamborlane W, Sherr J. Adjunctive Therapies for Type 1 Diabetes. Contemporary Endocrinology 2021, 143-150. DOI: 10.1007/978-3-030-64133-7_13.
- Commentary "Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals"
- Nally LM, Wagner J, Sherr J, Tichy E, Weyman K, Ginley MK, Zajac K, Desousa M, Shabanova V, Petry NM, Tamborlane WV, Van Name M. A Pilot Study of Youth With Type 1 Diabetes Initiating Use of a Hybrid Closed-Loop System While Receiving a Behavioral Economics Intervention. Endocrine Practice 2020, 27: 545-551. PMID: 34120699, PMCID: PMC8206518, DOI: 10.1016/j.eprac.2020.11.017.
- Nally LM, Lipska KJ. Expensive Insulin—The Epicenter of a Large, Life-Threatening Problem. JAMA Internal Medicine 2020, 180: 931-933. PMID: 32478822, DOI: 10.1001/jamainternmed.2020.1299.
- Nally L, Sherr J. Chapter 16 The dawn of automated insulin delivery: from promise to product. 2020, 327-356. DOI: 10.1016/b978-0-12-816714-4.00016-8.
- 8. Nally, LM, Sherr, JL. (2020) “Chapter 16. The Dawn of Automated Insulin Delivery: From Promise to Product.” In Fabris (Ed.), Glucose Monitoring Devices: Measuring Blood Glucose to Manage and Control Diabetes (pp.237-356). Philadelphia, PA: Elsevier.
- VanBaak KD, Nally LM, Finigan RT, Jurkiewicz CL, Burnier AM, Conrad BP, Khodaee M, Lipman GS. Wilderness Medical Society Clinical Practice Guidelines for Diabetes Management. Wilderness And Environmental Medicine 2019, 30: s121-s140. PMID: 31753543, PMCID: PMC7510348, DOI: 10.1016/j.wem.2019.10.003.
- Ekhlaspour L, Nally LM, El-Khatib FH, Ly TT, Clinton P, Frank E, Tanenbaum ML, Hanes SJ, Selagamsetty RR, Hood K, Damiano ER, Buckingham BA. Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting. Journal Of Diabetes Science And Technology 2019, 13: 1001-1007. PMID: 31470740, PMCID: PMC6835195, DOI: 10.1177/1932296819872225.
- Nally LM, Sherr JL, Van Name MA, Patel AD, Tamborlane WV. Pharmacologic treatment options for type 1 diabetes: what’s new? Expert Review Of Clinical Pharmacology 2019, 12: 471-479. PMID: 30892094, PMCID: PMC6488361, DOI: 10.1080/17512433.2019.1597705.
- Nally LM, Bondy N, Doiev J, Buckingham BA, Wilson DM. A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 2019, 21: 170-176. PMID: 30839229, DOI: 10.1089/dia.2018.0337.
- NALLY L, BONDY N, DOIEV J, BUCKINGHAM B, WILSON D. A Feasibility Study to Detect Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring. Diabetes 2018, 67 DOI: 10.2337/db18-906-p.
- Nally L, Wilson D. KCNJ11 R201C – Neonatal Diabetes. 2018, 61-66. DOI: 10.2337/9781580406666.case6.
- Was A, Lee H, Nally L, Arain Y. Case 3: An Infant with Severe Dehydration, Weight Loss, and Abnormal Newborn Screening Test Results. NeoReviews 2018, 19: e48-e50. DOI: 10.1542/neo.19-1-e48.
- Li R, Buras E, Lee J, Liu R, Liu V, Espiritu C, Ozer K, Thompson B, Nally L, Yuan G, Oka K, Chang B, Samson S, Yechoor V, Chan L. Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice. Gene Therapy 2015, 22: 876-882. PMID: 26172077, PMCID: PMC4636470, DOI: 10.1038/gt.2015.62.
- Pediatric Specialty Center at Long Wharf1 Long Wharf DriveNew Haven, CT 06511
Biography
Long before she knew she would become a pediatric endocrinologist, Laura Nally, MD, was familiar with type 1, or juvenile, diabetes. Her father and two of her aunts had the chronic condition, in which the pancreas creates too little or no insulin, a hormone needed to move blood sugar (glucose) to the body’s cells to be used for energy.
When she was 6, Dr. Nally was diagnosed with type 1 diabetes herself. “I’ve lived with it ever since. As I grew older, I knew I wanted to contribute to helping others with their management of type 1 diabetes,” says Dr. Nally, who specializes in treating children with diabetes and other hormonal problems. “When I was 12, I started to better understand how to manage the disease, and it became more interesting to me. Each day was like a science experiment. I’d take a certain amount of insulin, eat something, and then see what happened throughout the day.”
That fascination prompted her career in medicine. Pediatrics, she says, was a natural fit. “Kids are fantastic. I love working with them. I can be goofy and silly, which suits me naturally. It’s so nice to bond with them about diabetes,” she adds. “When I say, ‘Oh look, I have an insulin pump, too,’ the younger ones especially love that.”
Dr. Nally says she especially likes working with teenagers who have diabetes. “Life is difficult enough when you’re a teen, and to manage diabetes when you have 30 other things going on that are much more important to you is challenging,” she says. “I want to inspire them to take their insulin, to do their blood-sugar checks, but to not feel like their whole world revolves around diabetes. I think it helps for them to see me, a healthy, happy adult with diabetes who hasn’t let it stop her from achieving her dreams.”
Titles
- Assistant Professor of Pediatrics
- Assistant Professor, Pediatric Endocrinology & Diabetes
Education & Training
- FellowshipStanford University (2018)
- Pediatrics ResidentUC Irvine/CHOC Children's Hospital (2015)
- Pediatrics InternUC Irvine/CHOC Children's Hospital (2013)
- General Surgery InternUniversity of Rochester (2011)
- MDUC Davis School of Medicine (2010)
- BSRice University
Additional Information
- Letter of Distinction in Clinical Teaching: Stanford University School of Medicine (2018)
- Pediatric Outpatient Teaching Award: Stanford University School of Medicine (2017)
- Alpha Omega Alpha Honor Medical Society: Stanford University School of Medicine (2017)
- AAP Young Physician Community Engagement Award: American Academy of Pediatrics (2013)
- Gabriel Smilkstein Humanitarian Award: UC Davis School of Medicine (2010)
- Gold Foundation Scholarship: Gold Foundation (2010)
- Doctors For America (2021 - Present): Member
- American Academy of Pediatrics (2019 - Present): Member
- Borden C, Bakkila B, Nally L, Lipska K. The Association Between Cost-Related Insulin Rationing and Health Care Utilization in U.S. Adults With Diabetes. Diabetes Care 2025, 48: 400-404. PMID: 39746142, PMCID: PMC11870294, DOI: 10.2337/dc24-2117.
- Nally L, Sherr J. Making diabetes technology accessible to all. Nature Medicine 2024, 30: 1832-1833. PMID: 38918631, DOI: 10.1038/s41591-024-03082-8.
- Nally L, Sherr J, Tichy E, Weyman K, Urban A, Shabanova V, McCollum S, Steffen A, Tamborlane W, Van Name M. Impact of school‐supervised ultra‐long‐acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study. Diabetic Medicine 2023, 40: e15123. PMID: 37078999, PMCID: PMC10524154, DOI: 10.1111/dme.15123.
- Sherr J, Nally L. Continuous ketone monitoring for diabetes: a new era for diabetes. The Lancet Diabetes & Endocrinology 2025, 13: 736-738. PMID: 40812954, DOI: 10.1016/s2213-8587(25)00220-7.
- Nally L, Sherr J, Garg S, Marks B, Laffel L, Pihoker C, Accacha S, Thrasher J, Abuzzahab M, Reed J, Ekhlaspour L, Belapurkar S, Shulman D, Sunil B, MacLeish S, Latif K, Forlenza G, Castorino K, Lal R, Bode B, Broyles F, Carlson A, Nwosu B, Shin J, Ma H, Salbato A, Cordero T, Treminio Y, McVean J, Rhinehart A, Vigersky R, Group F. Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor. Diabetes Technology & Therapeutics 2025 PMID: 40824839, DOI: 10.1177/15209156251368928.
- Igudesman D, Nally L, Grimshaw A, Gunderson C, Considine E, Jacobsen L, Tosur M, Gottlieb P, Hirsch I, Laffel L, Sherr J, Mathieu C, Pratley R. Dietary Patterns for Weight and Glycemic Management in Persons With Type 1 Diabetes: A Meta-analysis of Clinical Trials. The Journal Of Clinical Endocrinology & Metabolism 2025, dgaf448. PMID: 40795275, DOI: 10.1210/clinem/dgaf448.
- FITCH R, MOULD D, SHERR J, LAFFEL L, NALLY L, FERGUSON N. 2070-LB: Modeling to Assess the Impact of Liquid, Stable Glucagon for Mini-dosing in Pediatrics—A Simulated Pharmacokinetic and Pharmacodynamic Study. Diabetes 2025, 74 DOI: 10.2337/db25-2070-lb.
- ASH G, NALLY L, LUKASIK J, MAK S, GRIGGS S, (ELIAS) SPANAKIS I, FUCITO L, WEINZIMER S. 1904-LB: Usability and Acceptability of a Biometric Dashboard with Tailored Coaching Tips for Exercise by Adults with Type 1 Diabetes. Diabetes 2025, 74 DOI: 10.2337/db25-1904-lb.
- ASH G, MAK S, (ELIAS) SPANAKIS I, LUKASIK J, NALLY L, FUCITO L, WEINZIMER S. 1109-P: Physician Referral Pathway to a Commercially Marketed Digital Exercise Resource for Type 1 Diabetes—Implementation Metrics from a Clinical Trial. Diabetes 2025, 74 DOI: 10.2337/db25-1109-p.
- NALLY L, LUKASIK J, HERZOG R, MITTENDORFER B, GOSS A, SAVOYE M, ROSE P, MCCOLLUM S, SHABANOVA V, SHERR J. 1186-P: A Short-Term Low Carbohydrate Diet Improves Glycemia in Adolescents and Young Adults with Type 1 Diabetes—Results from a Randomized Crossover Study. Diabetes 2025, 74 DOI: 10.2337/db25-1186-p.
- Mak S, Nally L, Montoya J, Marrero R, DeJonckheere M, Joiner K, Nam S, Ash G. An Exergames Program for Adolescents With Type 1 Diabetes: Qualitative Study of Acceptability. JMIR Diabetes 2025, 10: e65665. PMID: 40238214, PMCID: PMC12159555, DOI: 10.2196/65665.
- Harel S, Lukasik J, Wilcox A, Lipska K, Weinzimer S, Suttiratana S, Nally L. “Can I afford to live today?” The emotional toll of navigating the healthcare system with type 1 diabetes. Frontiers In Endocrinology 2025, 16: 1555265. PMID: 40196455, PMCID: PMC11973976, DOI: 10.3389/fendo.2025.1555265.
- Blanchette J, Nally L, Wentzell K, Hughes A, Allen N, Litchman M. Insights on Improving Health Insurance Literacy in Diabetes. The Journal Of Clinical Endocrinology & Metabolism 2025, 110: s175-s186. PMID: 39998926, PMCID: PMC12054720, DOI: 10.1210/clinem/dgae706.
- O’Donovan A, Gorelik S, Nally L. Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies. Frontiers In Endocrinology 2025, 15: 1548761. PMID: 39936148, PMCID: PMC11811703, DOI: 10.3389/fendo.2024.1548761.
- O’Donovan A, Gorelik S, Nally L. Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies. Frontiers In Endocrinology 2024, 15: 1477101. PMID: 39568817, PMCID: PMC11576206, DOI: 10.3389/fendo.2024.1477101.
- Nally L, Blanchette J. Integrated Strategies to Support Diabetes Technology in Pregnancy. Obstetrics And Gynecology 2024, 144: 599-607. PMID: 39208437, PMCID: PMC11486578, DOI: 10.1097/aog.0000000000005710.
- Ash G, Nally L, Stults-Kolehmainen M, De Los Santos M, Jeon S, Brandt C, Gulanski B, Spanakis E, Baker J, Weinzimer S, Fucito L. Personalized Digital Health Information to Substantiate Human-Delivered Exercise Support for Adults With Type 1 Diabetes. Clinical Journal Of Sport Medicine 2023, 33: 512-520. PMID: 36715983, PMCID: PMC10898917, DOI: 10.1097/jsm.0000000000001078.
- Nally, LM, Sherr, JL, Tichy, E, et al. Impact of school-supervised ultra-long-acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study. Diabet Med. 2023; 00:e15123. doi:10.1111/dme.15123
- Wilcox A, Lipska K, Weinzimer S, Gujral J, Arakaki A, Kerandi L, Nally L. Navigating barriers to affording and obtaining insulin and diabetes supplies. Journal Of Diabetes 2022, 15: 71-75. PMID: 36562281, PMCID: PMC9870729, DOI: 10.1111/1753-0407.13344.
- Deshpande S, Weinzimer SA, Gibbons K, Nally LM, Weyman K, Carria L, Zgorski M, Laffel LM, Doyle FJ, Dassau E. Feasibility and Preliminary Safety of Smartphone-Based Automated Insulin Delivery in Adolescents and Children With Type 1 Diabetes. Journal Of Diabetes Science And Technology 2022, 18: 363-371. PMID: 35971681, PMCID: PMC10973844, DOI: 10.1177/19322968221116384.
- WILCOX A, MENCHER S, NALLY L, WEINZIMER S. 1025-P: Racial Disparities in Diabetes Distress and Technology Use in Adolescents with Type 1 Diabetes. Diabetes 2022, 71 DOI: 10.2337/db22-1025-p.
- Mencher SR, Weinzimer SA, Nally LM, Van Name M, Nunez-Smith M, Sadler LS. Technology Utilization in Black Adolescents with Type 1 Diabetes: Exploring the Decision-Making Process. Diabetes Technology & Therapeutics 2022, 24: 249-257. PMID: 35085444, PMCID: PMC11074720, DOI: 10.1089/dia.2021.0413.
- Nally LM. A commentary on: Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System. PracticeUpdate website. Available at: https://www.practiceupdate.com/content/qualitative-study-of-user-experiences-with-loop-an-open-source-automated-insulin-delivery-system/138310/65/8/1. Accessed July 21, 2022
- Waikar AR, Arora T, Haynes M, Tamborlane WV, Nally LM. Case Report: Managing Pregnancy With Type 1 Diabetes Using a Do-It-Yourself Artificial Pancreas System. Clinical Diabetes 2021, 39: 441-444. PMID: 34866788, PMCID: PMC8603326, DOI: 10.2337/cd20-0128.
- Ash GI, Stults-Kolehmainen M, Busa MA, Gaffey AE, Angeloudis K, Muniz-Pardos B, Gregory R, Huggins RA, Redeker NS, Weinzimer SA, Grieco LA, Lyden K, Megally E, Vogiatzis I, Scher L, Zhu X, Baker JS, Brandt C, Businelle MS, Fucito LM, Griggs S, Jarrin R, Mortazavi BJ, Prioleau T, Roberts W, Spanakis EK, Nally LM, Debruyne A, Bachl N, Pigozzi F, Halabchi F, Ramagole DA, Janse van Rensburg DC, Wolfarth B, Fossati C, Rozenstoka S, Tanisawa K, Börjesson M, Casajus JA, Gonzalez-Aguero A, Zelenkova I, Swart J, Gursoy G, Meyerson W, Liu J, Greenbaum D, Pitsiladis YP, Gerstein MB. Establishing a Global Standard for Wearable Devices in Sport and Exercise Medicine: Perspectives from Academic and Industry Stakeholders. Sports Medicine 2021, 51: 2237-2250. PMID: 34468950, PMCID: PMC8666971, DOI: 10.1007/s40279-021-01543-5.
- WILCOX A, KERANDI L, LIPSKA K, WEINZIMER S, NALLY L. 49-LB: Navigating Barriers to Affording and Obtaining Diabetes Treatment. Diabetes 2021, 70 DOI: 10.2337/db21-49-lb.
- Kravetz AM, Sanghavi P, Bhargava V, Shi RZ, Nally LM. Plasmapheresis as an Early Treatment for Severe Hypertriglyceridemia, Acute Pancreatitis, and Diabetic Ketoacidosis. AACE Clinical Case Reports 2021, 7: 315-319. PMID: 34522772, PMCID: PMC8426612, DOI: 10.1016/j.aace.2021.03.009.
- John-Henderson NA, Wright RC, Manke KJ, Fotuhi O, Zuckerman B, Nally L, Mueller CM. The Influence of Health Mindset on Perceptions of Illness and Behaviors Among Adolescents. International Journal Of Behavioral Medicine 2021, 28: 727-736. PMID: 33721232, DOI: 10.1007/s12529-021-09972-2.
- Nally L, Van Name M, Tamborlane W, Sherr J. Adjunctive Therapies for Type 1 Diabetes. Contemporary Endocrinology 2021, 143-150. DOI: 10.1007/978-3-030-64133-7_13.
- Commentary "Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals"
- Nally LM, Wagner J, Sherr J, Tichy E, Weyman K, Ginley MK, Zajac K, Desousa M, Shabanova V, Petry NM, Tamborlane WV, Van Name M. A Pilot Study of Youth With Type 1 Diabetes Initiating Use of a Hybrid Closed-Loop System While Receiving a Behavioral Economics Intervention. Endocrine Practice 2020, 27: 545-551. PMID: 34120699, PMCID: PMC8206518, DOI: 10.1016/j.eprac.2020.11.017.
- Nally LM, Lipska KJ. Expensive Insulin—The Epicenter of a Large, Life-Threatening Problem. JAMA Internal Medicine 2020, 180: 931-933. PMID: 32478822, DOI: 10.1001/jamainternmed.2020.1299.
- Nally L, Sherr J. Chapter 16 The dawn of automated insulin delivery: from promise to product. 2020, 327-356. DOI: 10.1016/b978-0-12-816714-4.00016-8.
- 8. Nally, LM, Sherr, JL. (2020) “Chapter 16. The Dawn of Automated Insulin Delivery: From Promise to Product.” In Fabris (Ed.), Glucose Monitoring Devices: Measuring Blood Glucose to Manage and Control Diabetes (pp.237-356). Philadelphia, PA: Elsevier.
- VanBaak KD, Nally LM, Finigan RT, Jurkiewicz CL, Burnier AM, Conrad BP, Khodaee M, Lipman GS. Wilderness Medical Society Clinical Practice Guidelines for Diabetes Management. Wilderness And Environmental Medicine 2019, 30: s121-s140. PMID: 31753543, PMCID: PMC7510348, DOI: 10.1016/j.wem.2019.10.003.
- Ekhlaspour L, Nally LM, El-Khatib FH, Ly TT, Clinton P, Frank E, Tanenbaum ML, Hanes SJ, Selagamsetty RR, Hood K, Damiano ER, Buckingham BA. Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting. Journal Of Diabetes Science And Technology 2019, 13: 1001-1007. PMID: 31470740, PMCID: PMC6835195, DOI: 10.1177/1932296819872225.
- Nally LM, Sherr JL, Van Name MA, Patel AD, Tamborlane WV. Pharmacologic treatment options for type 1 diabetes: what’s new? Expert Review Of Clinical Pharmacology 2019, 12: 471-479. PMID: 30892094, PMCID: PMC6488361, DOI: 10.1080/17512433.2019.1597705.
- Nally LM, Bondy N, Doiev J, Buckingham BA, Wilson DM. A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 2019, 21: 170-176. PMID: 30839229, DOI: 10.1089/dia.2018.0337.
- NALLY L, BONDY N, DOIEV J, BUCKINGHAM B, WILSON D. A Feasibility Study to Detect Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring. Diabetes 2018, 67 DOI: 10.2337/db18-906-p.
- Nally L, Wilson D. KCNJ11 R201C – Neonatal Diabetes. 2018, 61-66. DOI: 10.2337/9781580406666.case6.
- Was A, Lee H, Nally L, Arain Y. Case 3: An Infant with Severe Dehydration, Weight Loss, and Abnormal Newborn Screening Test Results. NeoReviews 2018, 19: e48-e50. DOI: 10.1542/neo.19-1-e48.
- Li R, Buras E, Lee J, Liu R, Liu V, Espiritu C, Ozer K, Thompson B, Nally L, Yuan G, Oka K, Chang B, Samson S, Yechoor V, Chan L. Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice. Gene Therapy 2015, 22: 876-882. PMID: 26172077, PMCID: PMC4636470, DOI: 10.1038/gt.2015.62.
- Pediatric Specialty Center at Long Wharf1 Long Wharf DriveNew Haven, CT 06511
- Pediatric Specialty Center at Long Wharf1 Long Wharf DriveNew Haven, CT 06511